Results 31 to 40 of about 3,774,379 (347)

In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection [PDF]

open access: yes, 2017
Pseudomonas aeruginosa is an opportunistic and frequently drug-resistant pulmonary pathogen especially in cystic fibrosis sufferers. Recently, the frog skin-derived antimicrobial peptide (AMP) Esc(1-21) and its diastereomer Esc(1-21)-1c were found to ...
Chen, Chen   +2 more
core   +1 more source

Evaluation of empiric therapy appropriateness, resistance patterns, and mortality in Pseudomonas aeruginosa infections in Jordan [PDF]

open access: yesExploration of Medicine
Aim: This study aimed to investigate the susceptibility patterns of Pseudomonas aeruginosa strains, examine infection characteristics, and evaluate the appropriateness of empiric antibiotic therapy.
Savana Sobh   +3 more
doaj   +1 more source

Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections

open access: yesAntibiotics, 2023
Human Pseudomonas infections have high morbidity and mortality rates. Pseudomonas bacteria can cause sepsis or septic shock; they produce biofilm and commonly exhibit a multidrug-resistant phenotype.
Giuseppe Pipitone   +10 more
doaj   +1 more source

Importance of site of infection and antibiotic selection in the treatment of carbapenem-resistant Pseudomonas aeruginosa sepsis [PDF]

open access: yes, 2018
In a retrospective analysis of 215 patients with carbapenem-resistant Pseudomonas aeruginosa sepsis, we observed a significantly higher risk of mortality associated with respiratory tract infection (risk ratio [RR], 1.20; 95 ...
Britt, Nicholas S   +6 more
core   +2 more sources

Chronic Airway Infection and Resistance Pattern in Children and Adults with Cystic Fibrosis in Oman: A Single-center Cross-sectional Study

open access: yesOman Medical Journal
Objectives: Cystic fibrosis (CF) is a multisystemic genetic disease. Progressive decline in lung function is the major cause of morbidity and mortality in this population, primarily related to chronic airway infection and recurrent pulmonary ...
Amjad Al Haddabi   +4 more
doaj   +1 more source

Cell-to-Cell Signaling and Pseudomonas aeruginosa Infections

open access: yesEmerging Infectious Diseases, 1998
Pseudomonas aeruginosa is a bacterium responsible for severe nosocomial infections, life-threatening infections in immunocompromised persons, and chronic infections in cystic fibrosis patients.
Christian Van Delden   +1 more
doaj   +1 more source

Biotimer assay: A reliable and rapid method for the evaluation of central venous catheter microbial colonization [PDF]

open access: yes, 2017
Adherent bacteria and biofilm frequently colonize central venous catheters (CVCs). CVC colonization is correlated to infections and particularly to bloodstream ones.
Antimo Cutone   +8 more
core   +1 more source

Virulence genes and antibiotic resistance of Pseudomonas aeruginosa isolated from patients in the Northwestern of Morocco

open access: yesJournal of Infection in Developing Countries, 2019
Introduction: Pseudomonas aeruginosa is an ubiquitous bacterium causes various community-acquired and nosocomial infections. In this investigation, we aimed to screen the antibiotic susceptibility patterns and the prevalence of virulence factor genes in
Chaimae Elmouaden   +4 more
doaj   +1 more source

The transmission of nosocomial pathogens in an intensive care unit: a space–time clustering and structural equation modelling approach [PDF]

open access: yes, 2010
We investigated the incidence of cases of nosocomial pathogens and risk factors in an intensive treatment unit ward to determine if the number of cases is dependent on location of patients and the colonization/infection history of the ward.
A. G. O'DONNELL   +6 more
core   +1 more source

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.

open access: yesClinical Infectious Diseases, 2023
BACKGROUND The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant infections.
P. Tamma   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy